Segment Information (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of Financial Information by Segment

The following tables present financial information by segment:

	Year Ended December 31, 2024
		Products & Healthcare Services		Patient Direct		Consolidated
Net revenue	$	8,020,771	$	2,680,112	$	10,700,883
Cost of goods sold		7,081,997		1,399,732
Distribution, selling and administrative expenses		879,671		1,030,120
Other operating expense (income), net		6,091		(9,895)
Segment income	$	53,012	$	260,155		313,167
Acquisition-related charges and intangible amortization						(86,543)
Exit and realignment charges, net						(110,162)
Goodwill impairment charge						(307,112)
Litigation and related charges (1)						(17,119)
Operating loss					$	(207,769)
Capital expenditures	$	50,050	$	178,112	$	228,162

	Year Ended December 31, 2023
		Products & Healthcare Services		Patient Direct		Consolidated
Net revenue	$	7,781,395	$	2,552,572	$	10,333,967
Cost of goods sold		6,873,254		1,335,553
Distribution, selling and administrative expenses		843,967		969,592
Other operating expense, net		6,365		564
Segment income	$	57,809	$	246,863		304,672
Acquisition-related charges and intangible amortization						(101,037)
Exit and realignment charges, net						(99,127)
Operating income					$	104,508
Capital expenditures	$	29,361	$	178,531	$	207,892

	Year Ended December 31, 2022
		Products & Healthcare Services		Patient Direct		Consolidated
Net revenue	$	7,898,397	$	2,057,078	$	9,955,475
Cost of goods sold		6,925,929		1,110,920
Distribution, selling and administrative expenses		802,669		752,152
Other operating (income) expense, net		(5,510)		258
Segment income	$	175,309	$	193,748		369,057
Acquisition-related charges and intangible amortization						(126,972)
Exit and realignment charges, net						(6,897)
Inventory valuation adjustment (2)						(92,275)
Operating income					$	142,913
Capital expenditures	$	49,824	$	116,758	$	166,582

		Years Ended December 31,
		2024		2023		2022
Share-based compensation:
Products & Healthcare Services	$	19,417	$	15,078	$	19,681
Patient Direct		5,714		5,864		820
Other (3)		1,705		2,276		492
Consolidated share-based compensation:	$	26,836	$	23,218	$	20,993
Depreciation and amortization:
Products & Healthcare Services	$	45,835	$	47,756	$	51,784
Patient Direct		141,032		152,583		98,036
Intangible amortization		64,943		83,522		78,847
Other (4)		12,965		3,516		-
Consolidated depreciation and amortization:	$	264,775	$	287,377	$	228,667

(1) Litigation and related charges includes settlement costs and related fees of legal matters within our Apria division, which do not occur in the ordinary course of our business, are non-recurring/infrequent and are inherently unpredictable in timing and amount. These charges are reported within Other operating (income) expense, net in our Statements of Operations for the year ended December 31, 2024.

(2) Relates to an inventory valuation adjustment in our Products & Healthcare Services segment, primarily associated with PPE inventory built up and a subsequent decline in demand as a result of the COVID-19 pandemic.

(3) Other share-based compensation expense is captured within exit and realignment charges, net or acquisition-related charges and intangible amortization for the years ended December 31, 2024, 2023 and 2022.

(4) Other depreciation and amortization expense is captured within exit and realignment charges, net for the years ended December 31, 2024 and 2023.

Schedule of Consolidated Total Assets

	December 31, 2024		December 31, 2023
Total assets:
Products & Healthcare Services	$	2,429,513	$	2,359,825
Patient Direct		2,177,261		2,490,460
Segment assets		4,606,774		4,850,285
Cash and cash equivalents		49,382		243,037
Consolidated total assets	$	4,656,156	$	5,093,322

Schedule of Financial Information by Geographic Area

Years Ended December 31,	2024		2023		2022
Net revenue:
United States	$	10,457,942	$	10,058,675	$	9,526,037
International		242,941		275,292		429,438
Consolidated net revenue	$	10,700,883	$	10,333,967	$	9,955,475

December 31,	2024		2023
Long-lived assets:
United States	$	1,100,396	$	1,140,303
International		104,489		109,504
Consolidated long-lived assets	$	1,204,885	$	1,249,807